Special Issue "Natural Compounds as Potential Anticancer Agents"

A special issue of Medicines (ISSN 2305-6320).

Deadline for manuscript submissions: closed (31 July 2019).

Special Issue Editor

Assist. Prof. Sabita Saldanha
E-Mail Website
Guest Editor
Department of Biological Sciences, Alabama State University, 1627 Harris Way, Montgomery, AL 36101, USA
Interests: cancer epigenetics; biomarkers; bioactive molecules

Special Issue Information

Dear Colleagues,

Surgical resection, chemotherapy and radiation are the accepted medical practices in cancer treatment. Nonetheless, these treatment strategies (chemotherapy and radiation) may induce a plethora of adverse effects and drug tolerance over time. Alternate forms to the commonly used medical practices are therefore pertinent. The scope and aims of this Special Issue are to compile articles, original research, clinical trials, and/or review that address the latest developments in alternate therapies using natural compounds. In this issue, natural products will include molecules obtained from animals, plants or insects and is not restricted to bioactive molecules only. Studies that focus on the mechanistic action of these natural products and their relevance to chemotherapy will be accepted for this issue.

Assist. Prof. Sabita Saldanha
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • chemotherapy
  • epigenetics
  • medicinal plants
  • insect-derived products
  • animal-derived products
  • miRNA
  • bioactive molecules

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Open AccessReview
Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer
Medicines 2019, 6(1), 17; https://doi.org/10.3390/medicines6010017 - 23 Jan 2019
Cited by 2
Abstract
Breast cancer is still one of the most prevalent cancers and a leading cause of cancer death worldwide. The key challenge with cancer treatment is the choice of the best therapeutic agents with the least possible toxicities on the patient. Recently, attention has [...] Read more.
Breast cancer is still one of the most prevalent cancers and a leading cause of cancer death worldwide. The key challenge with cancer treatment is the choice of the best therapeutic agents with the least possible toxicities on the patient. Recently, attention has been drawn to herbal compounds, in particular ginsenosides, extracted from the root of the Ginseng plant. In various studies, significant anti-cancer properties of ginsenosides have been reported in different cancers. The mode of action of ginsenoside Rg3 (Rg3) in in vitro and in vivo breast cancer models and its value as an anti-cancer treatment for breast cancer will be reviewed. Full article
(This article belongs to the Special Issue Natural Compounds as Potential Anticancer Agents)
Show Figures

Figure 1

Back to TopTop